U.S. Senator Tommy Tuberville (R-Auburn) introduced legislation this week to protect Americans’ access to homeopathic medicine by building a new regulatory framework at the FDA.

The Homeopathic Drug Product Safety, Quality, and Transparency Act, co-sponsored by U.S. Senator Mike Lee (R-UT), would create a separate pathway for homeopathic products to gain FDA approval without forcing them through the same process designed for traditional pharmaceuticals.

“I’ve long been an advocate for homeopathic medicine,” Tuberville said. “The reality is that too many Americans today are hooked on pharmaceuticals when they could be using homeopathic remedies, which are often cheaper and can yield miraculous results. There’s no reason why the FDA shouldn’t be reviewing and approving some of these remedies to help Americans live healthier lives.”

The FDA first recognized homeopathic medicines in 1938 and regulated them for 80 years. In 2019, the agency withdrew that framework, throwing the industry into regulatory limbo and raising questions about the future of homeopathic products nationwide. The bill would reverse that shift by establishing homeopathic drug products as a distinct category with their own safety, labeling, and manufacturing standards.

The legislation earned endorsements from MAHA Action, the CPAC Foundation, Americans for Homeopathy Choice Action, the National Health Federation, the Health Freedom Defense Fund, and the Natural Products Association.

Tuberville has positioned himself as a leading voice on health policy in the Senate, pressing HHS Secretary Robert F. Kennedy Jr. earlier this year on rural hospitals and food safety as part of the broader Make America Healthy Again agenda.

Sawyer Knowles is a capitol reporter for Yellowhammer News. You may contact him at [email protected].